Caption Management »

Taysha Gene Therapies shares owned by Caption Management

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Caption Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.7M 491k 5.50
2022-03-31 $282k 43k 6.52

More positions owned by Caption Management

NVIDIA Corporation Call Option (NVDA)
Carvana Cl A Call Option (CVNA)
Intuit Call Option (INTU)
Warner Bros Discovery Com Ser A Call Option (WBD)
Tesla Motors Call Option (TSLA)
Amazon Put Option (AMZN)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Call Option (GOOG)
Reddit Cl A Call Option (RDDT)
Microsoft Corporation Call Option (MSFT)
United Therapeutics Corporation Call Option (UTHR)
Netflix Call Option (NFLX)
Boeing Company Call Option (BA)
Vertiv Holdings Com Cl A Call Option (VRT)
Oracle Corporation Call Option (ORCL)

View all positions for Caption Management

Top funds holding Taysha Gene Therapies

RA Capital Management
venBio Select Advisor
BlackRock
Rtw Investments
FMR
Vestal Point Capital
Goldman Sachs Group
Vanguard Group
State Street Corporation
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays
Geode Capital Management
Millennium Management

View all funds holding Taysha Gene Therapies